Activation of coagulation and fibrinolysis following OKT3 administration to renal transplant recipients: association with distinct mediators - PubMed (original) (raw)

Comparative Study

. 1992 Sep 7;68(3):264-7.

Affiliations

Comparative Study

Activation of coagulation and fibrinolysis following OKT3 administration to renal transplant recipients: association with distinct mediators

M H Raasveld et al. Thromb Haemost. 1992.

Abstract

Treatment with OKT3 induces cytokine release and activates the complement system. Since both phenomena may affect coagulation and fibrinolysis we studied these systems in 8 renal transplant recipients during OKT3 treatment. In 8 of 9 patients a similar pattern was observed: plasma thrombin-antithrombin-III-complex, tissue-type plasminogen-activator and plasmin-alpha 2-antiplasmin-complex levels were increased as compared to pretreatment levels (p less than 0.05) at 15 min after the first OKT3 dose and reached peak values at 1 h. No significant changes were observed upon subsequent OKT3 administrations or in a control group of 8 patients. In one patient upon the first OKT3 administration only complement activation, and no cytokine release was observed, whereas plasma thrombin-antithrombin-III-complex, tissue-type plasminogen-activator and plasmin-alpha 2-antiplasmin-complex levels increased only at 15 min. In conclusion, we demonstrate a biphasic activation of coagulation and fibrinolysis upon the first OKT3 dose; the initial phase seems to be associated with complement activation, the later phase with cytokine release.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources